课题基金 / 基金详情

RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT #2244: EASY TO USE, LOW-COST MOLECULAR-BASED SARS-COV-2 TEST, HIGHLY SCALABLE

RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT #2244: EASY TO USE, LOW-COST MOLECULAR-BASED SARS-COV-2 TEST, HIGHLY SCALABLE
快速加速诊断 (RADX) 计划:技术项目
批准号:
10505980
负责人:
INGO CHAKRAVARTY
金额:
$29.45万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-30 至 2021-07-29

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
为了满足Accula SARS-CoV-2检测大流行规模部署的需求,梅萨生物技术公司将通过快速扩建设施来扩大制造规模,每天生产60,000个检测。目前的制造产量约为每天2,000个测试。我们提议分两个阶段扩大制造规模,在资金到位后的四周内,通过增加生产线和扩大可以迅速到位的现有设施,将产量提高到每天6,000次测试。未来四个月的第二阶段产能扩张将通过增加一个新设施、额外的干室空间和额外的生产线来进一步提高产能,日产量最高可达60,000个测试。目前已有的Accula Dock仪器制造能力将支持每天生产50台Dock仪器。我们现有设施码头产量的小幅增长将使这一产量增加到200个码头/天,在未来4个月内生产额外的18,000个码头。鉴于Dock制造过程使用标准的电子设备制造方法,Dock制造能力还可以通过使用合同制造来进一步增强。因此,拟议的工作重点是扩大测试盒的生产规模,这需要通过扩大梅萨生物技术的制造能力来最好地实现专门的制造工艺。
英文摘要
To address the need for pandemic-scale deployment of the  Accula SARS-CoV-2 Test, Mesa Biotech will scale-up manufacturing by rapid facility expansion to produce 60,000 tests per day. Current manufacturing output is approximately 2,000 tests/day. We propose a two phase manufacturing scale-up to increase output, over the four weeks following the availability of funds, to 6,000 tests/day through the addition of production lines and expansion of the existing facility that can be rapidly put in place. A second phase expansion of manufacturing capacity over the next four months will further increase capacity through addition of a new facility, additional dry room space and additional production lines to an output of up to 60,000 tests/day. Accula Dock instrument manufacturing capacity currently in place will support the production of 50 Dock instruments per day. Modest increases in Dock production at our current facility will increase this output to 200 Docks/day, producing additional 18,000 docks in the coming 4 months. Given that the Dock manufacturing process makes use of standard electronic device manufacturing methods, Dock manufacturing capacity may also be further augmented through the use of contract manufacturing. Therefore, the proposed effort focuses on test cassette production scale-up which requires specialized manufacturing processes best achieved by expansion of manufacturing capacity at Mesa Biotech.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金